Female Post-Finasteride Syndrome: It’s Not Just A Man’s World

The document presents four studies from the 21st Annual Fall Scientific Meeting of SMSNA in 2015. The first study examines the prevalence of Post-Finasteride Syndrome (PFS) in women, finding that it represents a small but real subset of finasteride-related long-term adverse outcomes. The second study evaluates the availability and ease of purchase of anabolic androgenic steroids (AAS) and testosterone on the internet, concluding that they are readily available and remarkably easy to purchase without a prescription. The third study investigates the readability, credibility, and quality of patient-centered information on hypogonadism available online, finding that most websites are above the average American reading level and of questionable credibility and quality. The fourth study explores the relationship between plasma testosterone levels and markers of cardiovascular disease (CVD), revealing an inverse relationship between plasma testosterone level and the number of CVD biomarkers.